Navigation Links
Bionovo Announces Third Quarter 2009 Highlights and Financial Results
Date:11/5/2009

doplasmic reticulum (ER) of tumor cells. This dual effect of the drug activates cell suicide, or apoptosis, in tumor cells, but because these drugs do not inhibit mTORC1 and induce little ER stress in normal cells, normal cells are left unharmed.
  • Bionovo published the results of its study on the inhibitory effect of tamoxifen on estrogen receptor beta (ERb) gene regulation in the peer-reviewed journal, Molecular and Cellular Endocrinology. The results of this study demonstrate that tamoxifen inhibits the beneficial effects of ERb in the prevention of breast cancer cell proliferation. This suggests that there is a biological rationale for the development of ERb drugs for the treatment of breast cancer.
  • The Company announced the addition of Dr. Debu Tripathy, a leading researcher and clinician in the area of breast cancer, to its Medical Advisory Board. Dr. Tripathy is a Professor of Medicine at the Keck School of Medicine at the University of Southern California (USC) and Co-Leader of the Women's Cancer Program at USC Norris Comprehensive Cancer Center.
  • Third Quarter Results

    Total operating expenses for the three months ended September 30, 2009 were $3.9 million compared to $5.2 million for the same period in 2008 and $4.1 million for the second quarter of 2009. The decrease in year-over-year spending was primarily a result of a decrease in clinical activity and reduced employee headcount. Operating expenses in the third quarter of 2009 were primarily related to the Menerba manufacturing process development and commercial quality assurance procedures. Company management expects operating expenses to remain consistent through the fourth quarter at a burn rate of between $1 million and $1.5 million per month.

    The Company reported a net loss for the three months ended September 30, 2009 of $3.7 million, or $0.05 per share, compared with a net loss of $5.1 million, or $0.07 per share, for the same
    '/>"/>

    SOURCE Bionovo, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
    2. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
    3. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
    4. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
    5. Bionovo Announces First Quarter 2009 Highlights and Financial Results
    6. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
    7. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
    8. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
    9. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
    10. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
    11. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/27/2015)... JOSE, Calif. , May 27, ... (NASDAQ: MXIM ) makes it ... sensor and to monitor or control ... the DS28E80 gamma-radiation-resistant, nonvolatile (NV) 1-Wire® ... for DS28E80: http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html ...
    (Date:5/27/2015)... WINNIPEG, Manitoba , May 27, 2015 /PRNewswire-USNewswire/ ... American customers, the Canadian International Pharmacy Association ... prescription medications online from licensed Canadian pharmacies. Approximately 64% ... health maintenance medications from a non-U.S. pharmacy due ... medications are not covered under their insurance plan.   ...
    (Date:5/27/2015)... , May 27, 2015  Genomic Health, Inc. (Nasdaq: ... Operating Officer and Chief Financial Officer, will present at the ... City on Monday, June 1 at 8:30 a.m. ... subsequently archived webcast of the presentation, go to the  Investor ... .  Please connect to the web site at least 15 ...
    Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3
    ... (ERT), (Nasdaq: ERES ), a global provider ... medical device industries, today announced it has filed a ... and Exchange Commission (the "SEC").   While the Company ... offering of securities registered pursuant to the registration statement, ...
    ... 10, 2010 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation (OTC Bulletin ... manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese ... results for the third quarter ended September 30, 2010. ... Performance Revenue decreased 8.4% to $17.6 ...
    Cached Medicine Technology:ERT Files Shelf Registration Statement 2China Medicine Reports Third Quarter 2010 Financial Results 2China Medicine Reports Third Quarter 2010 Financial Results 3China Medicine Reports Third Quarter 2010 Financial Results 4China Medicine Reports Third Quarter 2010 Financial Results 5China Medicine Reports Third Quarter 2010 Financial Results 6China Medicine Reports Third Quarter 2010 Financial Results 7China Medicine Reports Third Quarter 2010 Financial Results 8China Medicine Reports Third Quarter 2010 Financial Results 9
    (Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), ... enterprise organizations, announced today that SanMar Corporation successfully ... time, attendance and point tracking processes for over ... States. , Family-owned since 1971, Seattle-based SanMar ... private label, and mill brands. SanMar supplies apparel ...
    (Date:5/27/2015)... In support of a new study ... Journal of American Geriatrics Society about the link between ... Commons OB-GYN P.A . is reiterating the nutritional value ... , To examine the relationship between diet soda intake ... Study of Aging (SALSA) tracked the soda consumption of ...
    (Date:5/27/2015)... Little Rock, AR (PRWEB) May 27, 2015 ... and Medix today announce a partnership to provide ... the Medix community. This collaboration seeks to strengthen ... skills measurement through CMSA’s CKP program. The mutually ... focused on identifying individual skills of talent in ...
    (Date:5/27/2015)... SAN DIEGO, May 27, 2015 – ... first healthcare provider along the Gulf Coast to ... (CCM). In partnership with MD Revolution, a digital ... new program that enables healthcare providers to easily ... This new, user-friendly program is designed to improve ...
    (Date:5/27/2015)... 2015 CompanionDx announced that ... genomic analysis in personalized cancer therapy: Non-small cell lung ... Society of Clinical Oncology (ASCO) as part of their ... , The molecular and clinical data used for the ... database. The study reports improved patient outcomes from a ...
    Breaking Medicine News(10 mins):Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3
    ... A coalition of concerned consumer advocate groups, including ... called on the New York State Legislature today to ... gifts to doctors. This ban would exclude prescription drug ... gifts valued at over fifty dollars. Pharmaceutical companies, in ...
    ... a wholly-owned subsidiary of Omron Healthcare, Inc.BANNOCKBURN, Ill., ... leading marketer of blood pressure monitors in North ... of M&M Medi-Medics, S.A. De C.V., a privately-held ... "Omron Healthcare is excited about this ...
    LOS ANGELES, Feb. 5 The Killeen Furtney Group, a Los Angeles marketing and public relations firm, announced today that their client, Ms. Nadya Suleman, mother of octuplets born last week, has selecte...
    ... finds , , THURSDAY, Feb. 5 (HealthDay News) -- ... adequately protected by existing federal government regulation, according ... Health Insurance Portability and Accountability Act (HIPAA) privacy ... authors said. They called on Congress to approve ...
    ... has provided critical insight into the genetic factors related to ... study, published by Cell Press in the February 6th issue ... to have a profound impact on the future design of ... cells (LSCs) were initially described as rare cells that share ...
    ... about the lawOLYMPIA, Wash., Feb. 5 The number of ... 2006, according to a new report. The annual rate of ... from nine percent in 2007 and five percent in 2006. ... is working with other state and local agencies to expand ...
    Cached Medicine News:Health News:Consumer Advocates Call on Legislature to Support Governor's Ban on Pharmaceutical Gifts to Doctors 2Health News:Consumer Advocates Call on Legislature to Support Governor's Ban on Pharmaceutical Gifts to Doctors 3Health News:Omron Healthcare, Inc. Acquires M&M Medi-Medics, S.A. De C.V. 2Health News:Private Health Care Info Needs Better Safeguards 2Health News:Leukemia stem cells have more in common with embryonic stem cells than adult stem cells 2Health News:More Retailers Selling Tobacco to Minors 2Health News:More Retailers Selling Tobacco to Minors 3
    ... The Thigh Cryo/Cuff combines the therapeutic ... and swelling, and cold to minimize pain. ... fit the thigh providing maximum cryotherapy.,All Cryo/Cuffs ... or with a cooler (including a tube ...
    ... The Leg Brace is designed ... fractures and the graduated management of ... leg.,The Leg Brace features anatomically designed ... aircell system. This exclusive system incorporates ...
    ... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
    Perfect for use in the E.R. Stabilizes collateral ligament strains in seconds and allows hand and finger function. Made from 1/8" AliPlast™ PXE. Can be scissor trimmed....
    Medicine Products: